Newly Diagnosed | TRIALNET Type 1 Diabetes TrialNet

Research interest leads first participant to join groundbreaking TOPPLE T1D study

Denver’s Max Hostetter, 22, says participating in TrialNet’s newest study is like peeking behind the curtain of T1D research into the future-- something people rarely ge

Research Spotlight

TrialNet Launches New Study Exploring Plasmid Therapy

Now enrolling adults diagnosed with T1D in the past 4 years

TrialNet is excited to announce the launch of our first Phase 1 clinical study to test a new plasmid therapy. The study will enroll 48 adults (age 18-45) diagnosed with type 1 diabetes (T1D) in the past 4 years.

Subscribe to Newly Diagnosed

Get in Touch

Type 1 Diabetes TrialNet
Phone: 1-800-425-8361
MON-FRI 8am-5pm ET

Quick Links

T1D Risk Screening
TrialNet Prevention Studies
The Stages of Type 1 Diabetes
Frequently Asked Questions
For Researchers
Member Login

Find a Location

Over 100 risk screening and study locations worldwide. Find A Location

Stay Connected

Follow TrialNet for important T1D research news and updates on social media or join our mailing list.